Business Description
Lakewood-Amedex Biotherapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US51255A1025
Description
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -14.5 | |||||
Debt-to-Equity | -0.62 | |||||
Debt-to-EBITDA | -0.52 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 29.01 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.11 | |||||
9-Day RSI | 19.04 | |||||
14-Day RSI | 16.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -22.99 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -644.92 | |||||
ROIC % | -189.35 | |||||
ROC (Joel Greenblatt) % | -2060.12 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -2.3 | |||||
EV-to-EBITDA | -2.34 | |||||
EV-to-FCF | -10.31 | |||||
Earnings Yield (Greenblatt) % | -43.48 | |||||
FCF Yield % | -12.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LABT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lakewood-Amedex Biotherapeutics Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.904 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 16.44 | ||
| 14-Day ATR ($) | 2.015344 | ||
| 20-Day SMA ($) | 5.8988 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 3.26 - 98.2 | ||
| Shares Outstanding (Mil) | 1.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lakewood-Amedex Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lakewood-Amedex Biotherapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2026-06-22 | 3.86 (-31.42%) |
Show
Entries
Lakewood-Amedex Biotherapeutics Inc Frequently Asked Questions
What is Lakewood-Amedex Biotherapeutics Inc(LABT)'s stock price today?
The current price of LABT is $3.55. The 52 week high of LABT is $98.20 and 52 week low is $3.26.
When is next earnings date of Lakewood-Amedex Biotherapeutics Inc(LABT)?
The next earnings date of Lakewood-Amedex Biotherapeutics Inc(LABT) is .
Does Lakewood-Amedex Biotherapeutics Inc(LABT) pay dividends? If so, how much?
Lakewood-Amedex Biotherapeutics Inc(LABT) does not pay dividend.
Guru Commentaries on NAS:LABT
No articles.
Press Release
Articles on Lakewood-Amedex Biotherapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers